Indivior Pharmaceuticals (INDV) Leases (2022 - 2025)
Historic Leases for Indivior Pharmaceuticals (INDV) over the last 4 years, with Q3 2025 value amounting to $30.0 million.
- Indivior Pharmaceuticals' Leases fell 1891.89% to $30.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.0 million, marking a year-over-year decrease of 1891.89%. This contributed to the annual value of $39.0 million for FY2024, which is 250.0% down from last year.
- Indivior Pharmaceuticals' Leases amounted to $30.0 million in Q3 2025, which was down 1891.89% from $35.0 million recorded in Q2 2025.
- In the past 5 years, Indivior Pharmaceuticals' Leases ranged from a high of $40.0 million in Q4 2023 and a low of $30.0 million during Q3 2025
- Its 4-year average for Leases is $34.5 million, with a median of $35.0 million in 2023.
- Its Leases has fluctuated over the past 5 years, first skyrocketed by 2903.23% in 2023, then tumbled by 1891.89% in 2025.
- Over the past 4 years, Indivior Pharmaceuticals' Leases (Quarter) stood at $31.0 million in 2022, then grew by 29.03% to $40.0 million in 2023, then dropped by 2.5% to $39.0 million in 2024, then decreased by 23.08% to $30.0 million in 2025.
- Its Leases stands at $30.0 million for Q3 2025, versus $35.0 million for Q2 2025 and $37.0 million for Q1 2025.